FY2026 · ended Apr 30, 2026 · Revenue $95.13M, +59.0% YoY · Filed Jul 14, 2026
Kestra Medical Technologies, Ltd. (KMTS) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2026, which ended Apr 30, 2026, it reported revenue of $95.1 million and a net loss of $131.6 million. Free cash flow was -$116.6 million. As of Jul 31, 2026 it held $244.7 million in cash and investments and $74.1 million in total debt.
Revenue (TTM)
$71.42M
Net income (TTM)
$-132.07M
Operating cash flow (TTM)
$-83.63M
Free cash flow (TTM)
$-106.73M
EPS (TTM)
$-5.47
Dividend per share
None
Shares outstanding
58.60M
+14.1% vs prior year
Net cash
$170.62M
as of Jul 31, 2026
Operating margin
-161.3%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- KMTS (Nasdaq)
- Fiscal year ends
- April 30
- Incorporated in
- Bermuda
- Headquarters
- Kirkland, WA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1877184
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2026 Apr 30, 2026 |
FY 2025 Apr 30, 2025 |
|---|---|---|
| Revenue | $95.1M | $59.8M |
| Operating income | -$134.7M | -$106.4M |
| Net income | -$131.6M | -$113.8M |
| Diluted EPS | -$2.43 | -$5.13 |
| Operating cash flow | -$81.7M | -$77.6M |
| Free cash flow | -$116.6M | -$100.5M |
| Total assets | $358.5M | $295.7M |
| Total liabilities | $98.8M | $90.3M |
| Stockholders' equity | $259.7M | $205.4M |
| Cash and investments | $262.2M | $237.6M |
| Total debt | $46.8M | $44.3M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Sep 14, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Results of operations
|
Sep 14, 2026 | Sep 14, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Sep 10, 2026 | Sep 9, 2026 |
| ARS | Annual report to shareholders | Jul 28, 2026 | Apr 30, 2026 |
| 10-K | Annual report | Jul 14, 2026 | Apr 30, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended, Results of operations, New debt
|
Jul 14, 2026 | Jul 10, 2026 |
All 186 Kestra Medical Technologies, Ltd. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.